Sensor helps reduce hospital readmission

The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce hospital admissions when used by physicians to manage heart failure.

The system features a sensor that is implanted in the pulmonary artery during a non-surgical procedure to directly measure artery pressure. Increased pressures appear before weight and blood pressure changes, which are often used as indirect measures that indicate worsening heart failure.

The new system allows patients to transmit daily sensor readings from their homes to their health care providers, allowing for personalized and proactive management of the condition and reduce complications and readmissions for care.

For more information, contact the Richmond Cardiology Associates office.